Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Amminger

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Schizophrenia Research|October 23, 2017
The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quoM J McHugh, P D McGorry, H P Yuen, et al.
The Lancet. Psychiatry|August 3, 2019
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trialChristopher G Davey, Andrew M Chanen, Sarah E Hetrick, et al.
NPJ Schizophrenia|June 27, 2018
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical courseB Nelson, G P Amminger, H P Yuen, et al.
Schizophrenia Research|December 24, 2019
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomesS Youn, L J Phillips, G P Amminger, et al.
Early Intervention in Psychiatry|July 30, 2013
Transitions Study of predictors of illness progression in young people with mental ill health: study methodologyR Purcell, A F Jorm, I B Hickie, et al.
Schizophrenia Research|December 13, 2018
Dynamic prediction of transition to psychosis using joint modellingH P Yuen, A Mackinnon, J Hartmann, et al.
Schizophrenia Research|April 20, 2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?H Hadar, H Zhang, L J Phillips, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Schizophrenia Research|October 23, 2017
The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quoM J McHugh, P D McGorry, H P Yuen, et al.
The Lancet. Psychiatry|August 3, 2019
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trialChristopher G Davey, Andrew M Chanen, Sarah E Hetrick, et al.
NPJ Schizophrenia|June 27, 2018
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical courseB Nelson, G P Amminger, H P Yuen, et al.
Schizophrenia Research|December 24, 2019
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomesS Youn, L J Phillips, G P Amminger, et al.
Early Intervention in Psychiatry|July 30, 2013
Transitions Study of predictors of illness progression in young people with mental ill health: study methodologyR Purcell, A F Jorm, I B Hickie, et al.
Schizophrenia Research|December 13, 2018
Dynamic prediction of transition to psychosis using joint modellingH P Yuen, A Mackinnon, J Hartmann, et al.
Schizophrenia Research|April 20, 2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?H Hadar, H Zhang, L J Phillips, et al.
Pageof 5